Compounding IV medications is a burdensome manual process that carries considerable risks. As hospitals care for more acute inpatients, the demand for IV medications is on the rise.
With an eye on improving safety, increasing compliance and reducing waste, an increasing number of hospitals and health systems are looking to insource and automate their IV compounding processes.
At Duke University Hospital in Durham, North Carolina, the decision to utilize a compounding robot has yielded positive results.
“It was our first attempt at using technology to bring back in-house items that we were purchasing in premixed doses,” said Udobi Campbell, associate chief pharmacy officer.Read More On www.healthcareitnews.com